Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

BACKGROUND: Fingolimod is a sphingosine‐1‐phosphate receptor modulator for the treatment of relapsing–remitting multiple sclerosis (RRMS). Despite an established effect on heart rate, the effect of fingolimod on cardiac repolarization is not completely known. METHODS: Twenty‐seven patients with RRMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Laiho, Aapo, Laitinen, Tiina M., Hartikainen, Päivi, Hartikainen, Juha E. K., Laitinen, Tomi P., Simula, Sakari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822581/
https://www.ncbi.nlm.nih.gov/pubmed/29484274
http://dx.doi.org/10.1002/brb3.925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822581/
https://www.ncbi.nlm.nih.gov/pubmed/29484274
http://dx.doi.org/10.1002/brb3.925

Ejemplares similares